US News

Pfizer agrees to pay $345 million to resolve EpiPen pricing lawsuit

Published by
Reuters

(Reuters) – Pfizer Inc has agreed to pay $345 million to resolve claims by consumers who claim they overpaid for EpiPens due to anticompetitive and unfair practices by the drugmaker and the company that markets the emergency allergy treatment, Mylan. The proposed class action settlement was disclosed in a filing in federal court in Kansas City, Kansas. The deal, which requires a judge’s approval, would not resolve claims against Mylan, which is scheduled to face trial in January. Paul Geller, a lawyer for the plaintiffs, said they were “pleased that Pfizer resolved its part of this class actio…

Read More

Facebook Comments

Check Also

With eye on China, Pentagon chief heads to Southeast Asia

Published by Reuters By Idrees Ali FAIRBANKS, Alaska ...

Archives